ZYME Q1 2023 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena

ZYMEZymeworks Inc.

$2B

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$36M+1756.9% YoY

Gross Profit

-$10M-27.6% margin

Operating Income

-$27M-76.7% margin

Net Income

-$24M-68.4% margin

EPS (Diluted)

$-0.36

QoQ Revenue Growth

-91.2%

Cash Flow

Operating Cash Flow

-$83M

Free Cash Flow

-$84M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$601M

Total Liabilities

$127M

Stockholders' Equity

$474M

Cash & Equivalents

$182M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$36M	$2M	+1756.9%
Gross Profit	-$10M	-$61M	+83.8%
Operating Income	-$27M	-$73M	+62.5%
Net Income	-$24M	-$73M	+66.5%

Revenue Segments

Research Support Payments And Other Service

$1M100%